Schneider LS, Caggiano AO, Grundman M, De Kosky S, Morgan R, Mozzoni K, Izzo NJ, Safferstein H, Catalano S. Clinical biomarker evidence for target engagement, reduction of synaptic damage and disease modification in Alzheimer’s patients treated with CT1812, poster abstract. Alzheimer's & Dementia, July 2019 Alzheimer's & Dementia

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. CT1812